Cibc World Market Inc. raised its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 61.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 191,278 shares of the company’s stock after buying an additional 72,498 shares during the period. Cibc World Market Inc. owned about 0.21% of Acadia Healthcare worth $5,260,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. acquired a new position in shares of Acadia Healthcare in the second quarter worth approximately $441,685,000. Jefferies Financial Group Inc. bought a new stake in Acadia Healthcare in the second quarter valued at approximately $106,458,000. Deutsche Bank AG acquired a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $49,746,000. First Trust Advisors LP increased its position in Acadia Healthcare by 73.0% during the 1st quarter. First Trust Advisors LP now owns 1,689,442 shares of the company’s stock valued at $39,516,000 after purchasing an additional 712,852 shares during the period. Finally, Braidwell LP raised its holdings in Acadia Healthcare by 76.7% during the 2nd quarter. Braidwell LP now owns 1,141,477 shares of the company’s stock worth $33,708,000 after purchasing an additional 495,577 shares during the last quarter.
Key Acadia Healthcare News
These are some of the ACHC news items that stood out recently:
- Positive Sentiment: Zacks Research raised its earnings estimates across multiple quarters and fiscal years, including FY2026 to $1.70 per share, FY2027 to $1.82, and FY2028 to $2.11. The firm maintained a “Strong-Buy” rating, signaling greater analyst confidence in Acadia’s earnings outlook. Zacks Research estimate updates
- Neutral Sentiment: A pre-market report said ACHC was indicated higher as traders considered Fed rate-hike talk and Treasury International Capital data; those macro factors could influence trading but do not represent a company-specific development. Acadia Healthcare pre-market report
- Negative Sentiment: The most recent report attributed a decline in Acadia shares to sector-wide selling, suggesting the weakness was part of broader healthcare-sector pressure rather than a company-specific announcement. Report on sector-wide selling
Acadia Healthcare Stock Performance
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.14. Acadia Healthcare had a negative net margin of 33.07% and a positive return on equity of 6.53%. The business had revenue of $895.31 million for the quarter, compared to analysts’ expectations of $877.76 million. During the same period in the previous year, the company earned $0.72 earnings per share. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.73 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
ACHC has been the subject of a number of analyst reports. Cantor Fitzgerald lifted their target price on shares of Acadia Healthcare from $30.00 to $39.00 and gave the stock a “neutral” rating in a research note on Friday, November 6th. Guggenheim increased their price target on Acadia Healthcare from $39.00 to $41.00 and gave the stock a “buy” rating in a report on Friday, November 6th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. Leerink Partners boosted their price objective on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research note on Wednesday, September 23rd. Finally, Royal Bank Of Canada upped their target price on Acadia Healthcare from $31.00 to $41.00 and gave the company an “outperform” rating in a research report on Friday, November 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Acadia Healthcare has an average rating of “Moderate Buy” and a consensus price target of $32.54.
Read Our Latest Report on ACHC
About Acadia Healthcare
Acadia Healthcare Company, Inc. is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care. Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.
See Also
- Five stocks we like better than Acadia Healthcare
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
